Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias - Summary - MDSpire

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • By

  • Dimitry S. Davydow

  • Gregory M. Pontone

  • Michael S. Okun

  • Melissa J. Armstrong

  • Theresa Wimberley Böttger

  • Camila Geels

  • Lise Marie Frohn

  • Jørgen Brandt

  • Julie Werenberg Dreier

  • Jakob Christensen

  • Carsten Bøcker Pedersen

  • Henriette Thisted Horsdal

  • May 14, 2026

  • 0 min

Share

Objective:

To examine the association between long-term exposure to PM2.5 and NO2 and the risk of diagnosis of dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), highlighting the significance of understanding environmental risk factors.

Key Findings:
  • Long-term exposure to PM2.5 and NO2 is associated with an increased risk of DLB and PDD, with specific statistical results to be included.
  • The study adjusted for sociodemographic characteristics and medical comorbidities, with details on the adjustments made.
Interpretation:

The findings suggest that air pollution may be a significant environmental risk factor for neurodegenerative diseases, particularly DLB and PDD, with implications for public health interventions.

Limitations:
  • The study is observational and cannot establish causation, with potential biases in observational studies.
  • Potential residual confounding despite adjustments for various factors.
Conclusion:

Long-term exposure to air pollutants, specifically PM2.5 and NO2, may contribute to the risk of developing DLB and PDD, highlighting the need for further research, particularly in intervention strategies.

Original Source(s)

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • by Dimitry S. Davydow, Gregory M. Pontone, Michael S. Okun, Melissa J. Armstrong, Theresa Wimberley Böttger, Camila Geels, Lise Marie Frohn, Jørgen Brandt, Julie Werenberg Dreier, Jakob Christensen, Carsten Bøcker Pedersen, Henriette Thisted Horsdal

  • May 14, 2026

Related Content

Neurobiological mechanisms of olfactory dysfunction: a ten-year bibliometric and visualization analysis

Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

Commentary: Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson's disease: a systematic review and meta-analysis